We’ve refreshed our website! Take a look around, tell us what you think, or revisit the archived site.

IMPORTANT: Find all anesthesia guides for individuals and their families and healthcare professionals

Join us at the 2026 MDF regional conference - Happening in a city near you!

Meet the DM Drug Developers

Do you have questions for DM drug developers? Check out this series of Meet the DM Drug Developers webinars.

About the webinar series

MDF’s Meet the DM Drug Developers webinar series connects the myotonic dystrophy community with leading biotechnology and pharmaceutical partners developing treatments and potential cures for DM. Building on the success of MDF’s 2020 Friday Afternoon Webinar Series, these live sessions offer participants the chance to hear updates directly from drug developers and ask questions in real time. Registration is required to join and submit questions in advance.

Thank you to our 2026 Community Education Webinar Series Sponsor, Avidity Biosciences!

Upcoming meetings

Fri, Apr 17, 2026

Meet the DM Drug Developer

Meet the DM Drug Developer: Avidity Biosciences

Register now!

Meet the DM Drug Developers recordings

Sort by:

Filter by:

PepGen - Meet the DM Drug Developers 2025

Published: November 7, 2025

PepGen presents an update on their DM program.

Clinical trials & drug approval

Sanofi - Meet the DM Drug Developers 2025

Published: October 9, 2025

Sanofi presents an update on their DM program.

ARTHEx Biotech - Meet the DM Drug Developers 2025

Published: August 7, 2025

ARTHEx Biotech presents an update on their DM program, including the ATX-01 program for DM1 and an overview of the ArthemiR trial.

Dyne Therapeutics - Meet the DM Drug Developers 2025

Published: February 20, 2025

Thank you to, Dyne Therapeutics for supporting our Communication Education Webinar Series at the Gold Sponsor Level!

Lupin Neurosciences - Meet the DM Drug Developers 2024

Published: November 26, 2024

Lupin Neurosciences presents Mexiletine program myotonic dystrophy type 1 (DM1)-01 program.

ARTHEx Biotech - Meet the DM Drug Developers 2024

Published: October 8, 2024

Arthex Biotech presents myotonic dystrophy program, including ATX-01 program for DM1 and an overview of the ArthemiR trial.

Join the registry

Help provide an understanding of DM by joining the Myotonic Dystrophy Registry.

Drug development

View the drug development pipeline to follow research progress.

Event calendar

Join others in learning, sharing, and building community by attending an event.